The percentages of IL-21-producing CD134+CD4+ T-cells were not significantly different between SLE patients and HC (11.9 ± 11.2% vs. 16.6 ± 19.0%; p = 0.73). This evidence concerns the gene TNFRSF4 and systemic lupus erythematosus.